These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 7492626
21. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Maze R, Horie M, Hendrie P, Vadhan-Raj S, Tricot G, Gordon M, Nemunaitis J, Ashman LK, Broxmeyer HE. Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784 [Abstract] [Full Text] [Related]
22. In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions. Zauli G, Vitale M, Visani G, Marchisio M, Milani D, Capitani S. Br J Haematol; 1994 Mar; 86(3):461-7. PubMed ID: 7519034 [Abstract] [Full Text] [Related]
23. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394 [Abstract] [Full Text] [Related]
24. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. Strife A, Lambek C, Perez A, Darzynkiewicz Z, Skierski J, Gulati S, Haley JD, ten Dijke P, Iwata KK, Clarkson BD. Cancer Res; 1991 Sep 15; 51(18):4828-36. PubMed ID: 1893375 [Abstract] [Full Text] [Related]
25. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D, Strife A, Atzpodien J, Clarkson BD. Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231 [Abstract] [Full Text] [Related]
26. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S. Exp Hematol; 1988 Aug 15; 16(7):594-602. PubMed ID: 3260558 [Abstract] [Full Text] [Related]
27. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha. Ferrajoli A, Talpaz M, Zipf TF, Hirsch-Ginsberg C, Estey E, Wolpe SD, Estrov Z. Leukemia; 1994 May 15; 8(5):798-805. PubMed ID: 8182937 [Abstract] [Full Text] [Related]
28. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1. McCrady CW, Li F, Pettit GR, Grant S. Exp Hematol; 1993 Jul 15; 21(7):893-900. PubMed ID: 7686503 [Abstract] [Full Text] [Related]
29. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients. Lemoli RM, Fortuna A, Fogli M, Rosti G, Gherlinzoni F, Visani G, Catani L, Gozzetti A, Tura S. Acta Haematol; 1996 Jul 15; 95(3-4):164-70. PubMed ID: 8677737 [Abstract] [Full Text] [Related]
30. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow. Lu L, Xiao M, Li ZH, Jolliffe LK, Jones S, Broxmeyer HE, Weich N. Exp Hematol; 1995 Sep 15; 23(10):1130-4. PubMed ID: 7656932 [Abstract] [Full Text] [Related]
31. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M. Bot FJ, van Eijk L, Schipper P, Löwenberg B. Exp Hematol; 1989 Mar 15; 17(3):292-5. PubMed ID: 2645158 [Abstract] [Full Text] [Related]
32. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V, Ferguson KF, Heller G, Kernan NA. Exp Hematol; 1995 Dec 15; 23(14):1422-30. PubMed ID: 8542927 [Abstract] [Full Text] [Related]
33. The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors. Jacobsen SE, Ruscetti FW, Ortiz M, Gooya JM, Keller JR. Exp Hematol; 1994 Sep 15; 22(10):985-9. PubMed ID: 7522186 [Abstract] [Full Text] [Related]
35. Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Han ZC, Lu M, Li J, Defard M, Boval B, Schlegel N, Caen JP. Blood; 1997 Apr 01; 89(7):2328-35. PubMed ID: 9116276 [Abstract] [Full Text] [Related]
36. Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. Ottmann OG, Ganser A, Seipelt G, Eder M, Schulz G, Hoelzer D. Blood; 1990 Oct 15; 76(8):1494-502. PubMed ID: 2207325 [Abstract] [Full Text] [Related]
39. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes. Greenberger JS, Krensky AM, Messner H, Burakoff SJ, Wandl U, Sakakeeny MA. Exp Hematol; 1984 Oct 15; 12(9):720-7. PubMed ID: 6333354 [Abstract] [Full Text] [Related]
40. Chemokine regulation of hematopoiesis and the involvement of pertussis toxin-sensitive G alpha i proteins. Broxmeyer HE, Youn BS, Kim C, Hangoc G, Cooper S, Mantel C. Ann N Y Acad Sci; 2001 Jun 15; 938():117-27; discussion 127-8. PubMed ID: 11458498 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]